Service

MRI-Guided Prostate Biopsy Accreditation Readiness Consulting (IAC)

MRI-guided prostate biopsy accreditation is the Intersocietal Accreditation Commission (IAC) program that reviews a facility performing image-guided prostate biopsy with ultra-low field MRI against the IAC Standards for MRI Image-Guided Prostate Biopsy Procedures Accreditation. It is for imaging and urology organizations that offer, or are building, an image-guided prostate biopsy service. Integral Healthcare Solutions (IHS) maps responsibilities across imaging and urology and drafts the policies for IAC accreditation; your physicians own the procedure.

Last reviewed: October 2026. IAC and ACR pages opened October 3, 2026.

What is IAC MRI image-guided prostate biopsy accreditation?

The governing text is the IAC standards document for MRI image-guided prostate biopsy procedures. It took effect January 1, 2025, and IAC added an artificial intelligence guidance document to it on April 1, 2025 (IAC Standards, PDF opened October 3, 2026). IAC's launch announcement is dated January 8, 2025 and points interested facilities to an interest form (IAC announcement, page opened October 3, 2026).

The scope is set by field strength. The program standards cover biopsy and treatment procedures done with ultra-low field MRI, meaning under 0.2T. A facility that also runs high-field biopsy or treatment and wants accreditation turns to the IAC MRI standards for equipment and environmental safety (IAC Standards, PDF opened October 3, 2026).

The standards place the program under one physician lead, the Medical Director, who is responsible for the facility's staff and operations. The Medical Director appoints a Technical Manager, who oversees the technical staff and runs the facility day to day (IAC Standards). The working checklist is IAC's checklist for MRI image-guided prostate biopsy procedures, copyright 2025 (IAC Checklist, PDF opened October 3, 2026).

Who needs it and what triggers it

How IHS helps

IHS works from the IAC standards and checklist your organization holds. The process:

  1. Gap assessment. IHS compares the program against the IAC prostate biopsy standards and sends questionnaires to the imaging and urology teams.
  2. Responsibility map and evidence mapping. IHS maps who owns each requirement across both services, then crosswalks each requirement to the policy, credential or record that shows it is met.
  3. Drafting. IHS drafts policies, document controls and QI review procedures, plus procedural content for your urologists and radiologists to review, change and approve.
  4. Mock review. IHS reviews the evidence against the application and the site-visit checklist and lists the gaps.
  5. Readiness support. IHS keeps the QI records and evidence index current through the decision and the site visit.

What you supply: the standards, procedure volumes, credentials, and the urologists, radiologists and technologists who own procedure and imaging decisions.

The limit: procedural technique and imaging protocols are clinical. IHS covers the cross-service organization and documentation. Your organization submits the application and hosts the site visit.

What to have ready

Printable version of this checklist (PDF)

How it compares

The options below come from IAC's and ACR's own pages. Which applies depends on your equipment and what you want the credential to show.

OptionWhat the sources say
IAC MRI Image-Guided Prostate Biopsy accreditationCovers biopsy and treatment with ultra-low field (<0.2T) MRI (IAC Standards). The program's 2025 checklist gives a review time of about 4 weeks, and IAC's general review-decisions page gives 8 to 10 weeks (IAC review decisions, page opened October 3, 2026). Ask IAC which applies. The checklist puts the site visit within 12 months of the decision (IAC Checklist).
IAC MRI Standards (equipment and environmental safety for high-field units)High-field biopsy and treatment facilities seeking accreditation use the IAC MRI Standards for equipment and environmental safety alongside the procedural and safety standards of this program (IAC Standards).
ACR Prostate Cancer MRI Center designationACR lists a Prostate Cancer MRI Center designation on its designations page (ACR Designations, page opened October 3, 2026). We did not review its eligibility requirements for this page.

What it costs

IAC does not publish a fee for the MRI Image-Guided Prostate Biopsy program on the pages we reviewed, including the launch announcement; fees depend on scope. Ask IAC for the current fee when you request the application.

IHS scopes each engagement after a free introductory call.

What this is not

Frequently asked questions

What is IAC MRI image-guided prostate biopsy accreditation?

It is an IAC accreditation program for facilities performing image-guided prostate biopsy and treatment with ultra-low field MRI. The governing text is the IAC Standards for MRI Image-Guided Prostate Biopsy Procedures Accreditation, effective January 1, 2025, with an AI Guidance Document added April 1, 2025. IAC's launch announcement is dated January 8, 2025.

Does IAC prostate biopsy accreditation apply to 1.5T or 3T MRI biopsy, or only low-field systems?

The program standards are specific to ultra-low field (<0.2T) MRI. For a facility seeking accreditation for high-field biopsy, the standards route equipment and environmental safety questions to the IAC MRI standards. The same document says a facility may run both high and low field units, and that its procedural and safety requirements reach every facility that biopsies the prostate under MRI. The text can be read as placing high-field biopsy inside this program, with the IAC MRI Standards supplying the equipment and environmental safety requirements, or as sending high-field facilities to the MRI program. IAC's text does not say which, so that reading is IHS's and is for IAC to settle. A high-field facility should ask IAC in writing before building (IHS can draft the question, and your facility sends it).

Who can be medical director of an accredited MRI-guided prostate biopsy program?

The standards put the Medical Director in charge of all staff and operations. Standard 1.2A sets the physician qualifications for the ultra-low field (0.065T) system: at least 30 biopsies, counted across training and clinical practice, and board certification in a relevant specialty, for example Urology (ABU) or Radiology (ABR).

How many biopsies must physicians have performed to meet IAC standards?

For the ultra-low field (0.065T) system, which is the equipment the staff section addresses, Standard 1.2A sets a floor of 30 biopsies across training and clinical practice for the Medical Director and medical staff. The standards send staff pathways for other MRI units to the IAC MRI Standards. Keep a count for each physician with the records that support it.

How long does IAC prostate biopsy accreditation take, and when is the site visit?

IAC's checklist for this program gives a review time of about 4 weeks before a decision, and IAC's general review-decisions page gives 8 to 10 weeks (IAC review decisions, page opened October 3, 2026). Ask IAC which applies. The checklist puts the site visit within 12 months of the accreditation decision, with the site visitor observing procedures and evaluating documentation. IAC's review-decisions page also says a site visit is scheduled once a conditional grant is issued in image-guided procedures.

How much does IAC MRI-guided prostate biopsy accreditation cost?

IAC does not publish a fee for this program on the pages we reviewed, including the launch announcement. Fees depend on scope; ask IAC for the current fee. IHS scopes its own work after a free introductory call.

How do urology and radiology split responsibilities in an accredited biopsy program?

The standards set one structure: a Medical Director responsible for all staff and operations, and a Technical Manager appointed by the Medical Director who oversees technical staff and daily operations. How each service fills those roles is your organization's decision; IHS builds a responsibility map so every requirement has an owner.

What QI meetings and complication reviews does IAC require?

Standard 3.1C calls for at least two Quality Improvement meetings a year. Standard 3.1.1C has every significant complication reviewed, for example safety issues and adverse events.

What is the difference between IAC prostate biopsy accreditation and the ACR Prostate Cancer MRI Center designation?

IAC's program accredits facilities performing image-guided prostate biopsy and treatment with ultra-low field MRI against published standards. ACR lists a Prostate Cancer MRI Center designation on its designations page (ACR Designations, page opened October 3, 2026). We did not review the ACR designation's eligibility requirements for this page.

Does IHS perform procedures or submit our application?

No. Your urologists, radiologists and technologists own procedure and imaging decisions and approve what IHS drafts. Your organization submits the application and hosts the site visit; IHS drafts the policies, responsibility map and evidence index behind it.

Recent changes

  • CY 2027 Hospital Outpatient Prospective Payment System & Ambulatory Surgical Center Final Rule

    · Centers for Medicare & Medicaid Services

    Centers for Medicare & Medicaid Services states: “CMS issued a final rule that updates Medicare payment policies and rates for hospital outpatient and ambulatory surgical center (ASC) services under the Hospital Outpatient Prospective Payment System (OPPS) and ASC Payment System for CY 2027. This new CMS rule will expand outpatient surgery options, lower out-of-pocket costs for imaging services and 340B drugs, and strengthen oversight of select services.”

    Checked

  • Medicare Outpatient Final Rule Expands Surgical Options, Lowers Out-of-Pocket Costs for 340B Drugs

    · Centers for Medicare & Medicaid Services

    Centers for Medicare & Medicaid Services states: “A new Centers for Medicare & Medicaid Services (CMS) rule will expand outpatient surgery options, lower out-of-pocket costs for imaging services and 340B drugs, and strengthen oversight of select services. The rule also updates 2027 payment rates for hospital outpatient departments and ambulatory surgical centers (ASCs).”

    Who it applies to, in the source's words: “This policy already applies to clinic visits and drug administration services at those locations. CMS estimates the change would save beneficiaries and taxpayers a total of $260 million in CY 2027 and over $9 billion from CY 2027 to CY 2036. The rule also continues to phase out the "Inpatient Only" procedure list, which will allow more services to be delivered in outpatient settings, and it also continues to expand the ASC covered procedures list by several hundred surgical procedures. These changes give physicians more flexibility to choose an appropriate care setting and give patients more outpatient surgical options while maintaining patient safety.”

    Checked

  • Ohio: $92M to Coordinate Rural Hospital Networks, Improve Maternal Care & Expand Medical Services

    · Centers for Medicare & Medicaid Services

    Centers for Medicare & Medicaid Services states: “This federal investment will connect rural providers and bring MRI, behavioral health, and maternal care closer to patients across Ohio. The Trump Administration announced $92 million in Rural Health Transformation Program funding to help rural providers connect patients to coordinated, high-quality care and bring essential health services closer to home for Ohioans. This investment will support coordinated care networks, strengthen maternal health services, and upgrade equipment and facilities at 22 rural hospitals across Ohio.”

    Checked

More: Imaging and radiology · all standards changes

Talk with IHS's CEO

A 30-minute introductory meeting with Thomas G. Goddard, JD, PhD, to scope what your organization needs.

Schedule a Free Discovery Session